Safety of Nivestim® in Patients Treated With Neutropenia-inducing Anticancer Chemotherapy in Routine Practice
Phase of Trial: Phase IV
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Filgrastim (Primary) ; Filgrastim (Primary)
- Indications Febrile neutropenia
- Focus Adverse reactions
- Acronyms NEXT
- Sponsors Hospira
- 12 Dec 2015 Results of sub-group analysis (n=463) presented at the 38th Annual San Antonio Breast Cancer Symposium
- 14 Jun 2015 Results presented at the 20th Congress of the European Haematology Association.
- 14 Jun 2015 Results (subanalysis) presented at the 20th Congress of the European Haematology Association (n = 455).